T. Øverland

发表

Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders

Ivan K. Chinn, Eric A. Smith, J. Lupski, 2017, The Journal of allergy and clinical immunology.

Complement Activation in 22q11.2 Deletion Syndrome

T. Mollnes, T. Abrahamsen, T. Øverland, 2020, Journal of Clinical Immunology.

Increased Levels of Interferon‐Inducible Protein 10 (IP‐10) in 22q11.2 Deletion Syndrome

T. Mollnes, T. Øverland, K. Lima, 2016, Scandinavian journal of immunology.

Lymphocyte Apoptosis and FAS Expression in Patients with 22q11.2 Deletion Syndrome

T. Abrahamsen, T. Øverland, K. Lima, 2018, Journal of Clinical Immunology.

Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features

L. Baumbusch, L. Osnes, T. Abrahamsen, 2015, Journal of Clinical Immunology.

A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T‐cell dysfunction

J. Lupski, R. Gibbs, D. Muzny, 2016, Molecular genetics & genomic medicine.

Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency

A. Stray-Pedersen, Ruth Halsne, L. Osnes, 2020, Frontiers in Immunology.

Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features

L. Baumbusch, L. Osnes, T. Abrahamsen, 2015, Journal of Clinical Immunology.

Complement Activation in 22q11.2 Deletion Syndrome

T. Mollnes, T. Abrahamsen, T. Øverland, 2020, Journal of Clinical Immunology.